19.01.2012 08:35 Uhr, Quelle: Wallstreet online

DGAP-Adhoc: 4SC AG: 4SC´s cancer compound resminostat meets primary endpoint in Phase II trial in advanced liver cancer (HCC) ahead of schedule

4SC AG  / Key word(s): Miscellaneous19.01.2012 08:23Dissemination of an Ad hoc announcement according to § 15 WpHG, transmittedby DGAP - a company of EquityStory AG.The issuer is solely responsible for the content of this announcement.4SC´s …

Weiterlesen bei Wallstreet online